GPC Biotech AG (GPCB)

[surf1944]

GPC Biotech to Provide Update on Research and Development Programs at JPMorgan 26th Annual Healthcare Conference in San Francisco
Monday January 7, 10:52 am ET

MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.--(BUSINESS WIRE)--GPC Biotech AG (Frankfurt Stock Exchange: GPC; NASDAQ: GPCB) today announced that the Company will give a company update at the JPMorgan 26th Annual Healthcare Conference in San Francisco, CA. The Company will provide an update on its research and development pipeline. Additional information on satraplatin, including the SPARC trial and development plan for the compound, as well as updates on other programs, will be presented.

The presentation will be today, Monday, January 7, 2008, at 3:30 PM PST at the Westin St. Francis, San Francisco, CA. The presentation will be webcast live and will be accessible through the GPC Biotech Web site at www.gpc-biotech.com. A replay will also be available via the Web site.